Cancer stem cells can go it alone

June 11, 2007

At the heart of most, if not all cancers, lie a handful of wayward stem cells that feed the ever growing tumor mass, but their scarcity make it difficult for scientists to study them. Now, times of plenty may lie ahead as a breast cancer cell line – established long ago – turned out to behave a lot like cancer stem cells.

In a study to be published in this week’s online edition of the Proceedings of the National Academy of Sciences an international group of researchers led by Nobel Laureate Renato Dulbecco, M.D., a distinguished research professor and president emeritus of the Salk Institute, demonstrates that injection of a single cell taken from cultured LA7 cells into mouse breast tissue can seed a new mammary carcinoma.

Their finding supports the observation that although cancer stem cells are rare, in the bulk of a tumor, a single cancer stem cell is sufficient to initiate and maintain a malignant tumor. “We can use single cancer stem cells to study the dynamics and behavior of cancer stem cells and their role in solid tumor formation at the single cell level,” says lead author Ileana Zucchi, Ph.D., a molecular cancer biologist at the Institute for Biological Technology (ITB-CNR) in Milan, Italy.

Having a model cancer stem cell system will also allow researchers to identify genes and proteins that will help with the search for human breast cancer stem cells in the future. “As we learn more about tumor formation at the single cell level in tissue, we may be able to specifically target cancer stem cells for destruction while leaving the normal stem cells in the body intact,” hopes Zucchi.

Dulbecco had isolated the LA7 cells from a rat mammary adenocarcinoma back in 1979. He and Zucchi have spent the last decade studying their ability to generate the different structures that make up mammary glands. “We initially started to work with LA7 cells because they retain considerable stem cell potential and, therefore, behave like normal adult stem cells. But it wasn’t until later that we could demonstrate that a single LA7 cell can also form heterogenous tumors and behave also as a cancer stem cell,” remembers Zucchi.

The fact that tumor cells and stem cells share many properties has been known for quite some time. The ability of adult stem cells or cancer stem cells to divide and generate both new stem cells (called self-renewal) as well as specialized cell types (called differentiation) is the key to maintaining healthy tissues, and to keep tumors growing indefinitely in the case of cancer stem cells.

There’s a major difference, though. “Although normal stem cells show significant stem cell renewal, they are usually not associated with uncontrolled cell proliferation when they reside within their normal environment or niche. Cancer stem cells, however, are not equally responsive to environmental cues that repress uncontrolled cell proliferation of the stem cells,” explains Zucchi.

When grown in culture dishes, LA7 cells act just like normal stem cells and, when prodded with appropriate cues, differentiate into all the cell lineages found in the mammary gland. Given enough time, the cells form complex, three-dimensional structures resembling the milk-producing alveoli and ducts in normal breast tissue and start to produce milk proteins.

To assess the cells’ tumorigenic potential, the researchers injected the cells into the breast tissue of female mice. Unable to respond to conditions that prevent normal stem cells from spinning out of control, even a single LA7 cell started to form tumors. “If tumor induction was dependent on injecting more than one cell, it would be difficult to determine whether cells that appear to be resistant to these conditions are simply cell types different from cancer stem cells,” Zucchi says. “But since we start with a single cancer stem cell for injection, we know that the resistance must derive from the original cancer stem cell.”

Source: Salk Institute

Explore further: Bolstering fat cells offers potential new leukemia treatment

Related Stories

Bolstering fat cells offers potential new leukemia treatment

October 16, 2017
Killing cancer cells indirectly by powering up fat cells in the bone marrow could help acute myeloid leukemia patients, according to a new study from McMaster University.

Scientists identify biomarker for progression and drug response in brain cancer

October 16, 2017
Scientists at the Icahn School of Medicine at Mount Sinai, Sema4, and collaborating institutions including Colorado State University and Fred Hutchinson Cancer Center reported results today from a glioblastoma study in which ...

Areas of glioblastoma tumors correlate with separate subtypes of glioma stem cells

October 10, 2017
A new study published in the Oct. 9 issue of the journal Nature Medicine demonstrates, for the first time, that glioblastoma (GBM), the most common and most lethal brain tumor, is driven by two distinct subsets of cancer ...

Growing human brain cells in the lab

October 10, 2017
Li Gan, PhD, wants to find treatments to help patients with Alzheimer's disease. Like most researchers, she's hit a few major roadblocks.

Team finds a potentially better way to treat liver cancer

October 12, 2017
A Keck School of Medicine of USC research team has identified how cancer stem cells survive. This finding may one day lead to new therapies for liver cancer, one of the few cancers in the United States with an incidence rate ...

Scientists pinpoint surprising origin of melanoma

October 12, 2017
Led by Jean-Christophe Marine (VIB-KU Leuven), a team of researchers has tracked down the cellular origin of cutaneous melanoma, the deadliest form of skin cancer. The team was surprised to observe that these very aggressive ...

Recommended for you

Study shows how nerves drive prostate cancer

October 19, 2017
In a study in today's issue of Science, researchers at Albert Einstein College of Medicine, part of Montefiore Medicine, report that certain nerves sustain prostate cancer growth by triggering a switch that causes tumor vessels ...

Gene circuit switches on inside cancer cells, triggers immune attack

October 19, 2017
Researchers at MIT have developed a synthetic gene circuit that triggers the body's immune system to attack cancers when it detects signs of the disease.

One to 10 mutations are needed to drive cancer, scientists find

October 19, 2017
For the first time, scientists have provided unbiased estimates of the number of mutations needed for cancers to develop, in a study of more than 7,500 tumours across 29 cancer types. Researchers from the Wellcome Trust Sanger ...

Researchers target undruggable cancers

October 19, 2017
A new approach to targeting key cancer-linked proteins, thought to be 'undruggable," has been discovered through an alliance between industry and academia.

Suicide molecules kill any cancer cell

October 19, 2017
Small RNA molecules originally developed as a tool to study gene function trigger a mechanism hidden in every cell that forces the cell to commit suicide, reports a new Northwestern Medicine study, the first to identify molecules ...

Fundamental research enhances understanding of major cancer gene

October 19, 2017
New research represents a promising step towards better understanding of a key cancer gene. A long-running collaboration between researchers at the Babraham Institute, Cambridge and the AstraZeneca IMED Biotech Unit reveals ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.